European Healthtech startup funding raised during Q1 2022.
In Q1 2022, 171 European Healthtech companies raised a combined €2.7B across 171 funding rounds, up 70.3% versus Q1 2021. France led by capital raised, and Bpifrance was the most active investor. Data as of 9 Jul 2026.
19 exits · €4.2B disclosed.
| Pharma Intelligence | Acquisition | Feb 2022 | €2.3B |
| Zogenix | Acquisition | Jan 2022 | €1.7B |
| Optima | Acquisition | Jan 2022 | €162M |
| Klara | Acquisition | Feb 2022 | €87M |
| GP Service | Acquisition | Feb 2022 | €17M |
| €92M |
| Ori Biotech | Series B | Jan 2022 | €88M |
| Padoa | Other | Feb 2022 | €80M |
| Precirix | Series B | Mar 2022 | €80M |
| DistalMotion | Series D+ | Jan 2022 | €80M |
| Ambagon Therapeutics | Series A | Jan 2022 | €75M |
| Microbiotica | Series B | Mar 2022 | €61M |
| EyeBiotech | Series A | Feb 2022 | €57M |
| SpliceBio | Series A | Feb 2022 | €50M |
| InnovHeart | Series C | Jan 2022 | €49M |
| Engitix | Series A | Jan 2022 | €48M |
| Automata Technologies | Series B | Feb 2022 | €44M |
